Skip to content

To evaluate the Skin health enhancing ability of Kapiva Skin Foods Glow Mix- An Ayurvedic powder-based drink in healthy adult female face skin

An open label, prospective, single arm study to evaluate the Skin health enhancing ability of Kapiva Skin Foods Glow Mix- An Ayurvedic powder-based drink in healthy adult female face skin. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054901
Enrollment
20
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Adret Retail Pvt. Ltd. (Kapiva Ayurveda)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female adult subjects in general good health & age group of 30 to 50 years. 2. Subject must not have used any anti-aging cream before study enrolment and intend to use during the study. 3. Subject who agrees not to use any other product/treatment/home remedy/soap bar on their face during the study period other than the test product. 4. Subject with Fitzpatrick skin types III to V. 5. Subjects having visible fine lines and wrinkles in periorbital area like Crow’s feet-under eye & forehead as assessed by dermatologist. 6. Subjects having skin aging concerns as assessed by dermatologist 7. Subjects not having hair style which covers almost the entire forehead. 8. Subject free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face. 9. Subjects who agree not to carry out bleaching or any other procedures on face during the study period. 10. Subjects who agree not to expose to excessive sun light (Sun exposure not more than half an hour daily and during that time use of umbrella to cover face). 11. Subjects willing to give a voluntary written informed consent, photography release and agree to come for regular follow up. 12. Subjects willing to abide by and comply with the study protocol. 13. Subjects who have not participated in a similar investigation in past four weeks. 14. Subjects who are willing not to participate in any other clinical study during participation in the current study.

Exclusion criteria

Exclusion criteria: 1. Subjects using any anti-aging cream prior to study enrolment and intend to use during the study. 2. Subject with any other signs of significant local irritation or skin disease. 3. Subjects who experience nausea or vomiting due to the flavor or product will be excluded from the study 4. Subject currently taking any medication including food supplements, which the Investigator believes may influence the interpretation of the data. 5. Subjects showing abnormal levels in blood test parameters. (Subjects having abnormal values but are clinically fit to participate in the trial would be enrolled in the study at Principal Investigator’s Discretion). 6. Subject having chronic illness or had major surgery in the last year. 7. Subjects undergoing any treatment of any skin condition on their face/forearm/any. 8. Subjects not willing to discontinue other topical facial products. 9. Subjects with clinically significant cardiovascular, cerebrovascular, respiratory, liver, renal disease, congenital, or any other systemic condition requiring therapeutic intervention. 10. A known history or present condition of an allergic response to pharmaceutical products its components or ingredients in the test products. 11. Pre-existing systemic disease necessitating long-term medications. 12. Genetic and endocrinal disorders. 13. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Reduction in spots, pigmentation, wrinkles & fine lines. Subject photographs will be takenTimepoint: Day 1, Day 15, Day 30, Day 45, Day 60, Day 75 & Day 90

Secondary

MeasureTime frame
Subject photographs will be takenTimepoint: Day 1, Day 15, Day 30, Day 45, Day 60, Day 75 & Day 90

Countries

India

Contacts

Public ContactMeena Dalal

Trial Guna Pvt Ltd

drsohanshetty@yahoo.co.in8867125414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026